What is SMA? Spinal Muscular Atrophy - SMA Symptoms, Treatments, and Leading Specialists

Spinal Muscular Atrophy (SMA) is a genetic neuromuscular disorder that affects motor neuron cells in the spinal cord, leading to progressive muscle weakening and atrophy. Primarily affecting infants and children, SMA is a life-altering condition that requires specialized, comprehensive care from experienced medical professionals.

In this article, we’ll delve into the causes, symptoms, and treatment advancements for SMA, alongside an overview of top hospitals and Dr. Vivek Mundada, a highly skilled pediatric neurologist with extensive experience in treating children with complex neurological conditions, including SMA.

What is Spinal Muscular Atrophy (SMA)?

SMA is a genetic disorder caused by mutations in the SMN1 gene (Survival Motor Neuron 1), responsible for producing the SMN protein essential for motor neuron survival. When there is insufficient SMN protein, motor neurons begin to deteriorate, affecting the patient’s ability to perform basic movements such as walking, swallowing, and breathing.

Types of SMA

There are several types of SMA, categorized by the age of onset and severity of symptoms:

1. SMA Type 1 (Werdnig-Hoffmann Disease): Appearing within the first six months of life, this is the most severe form of SMA. Infants with SMA Type 1 experience muscle weakness, difficulty breathing and swallowing, and generally require immediate medical intervention.

2. SMA Type 2: Onset usually occurs between 6 and 18 months of age. Children with SMA Type 2 may be able to sit independently but are unlikely to stand or walk without support.

3. SMA Type 3 (Kugelberg-Welander Disease): This type appears between 18 months and early adulthood. While individuals with SMA Type 3 can walk independently, they may experience increased weakness and mobility challenges as they age.

4. SMA Type 4: Typically appears in adulthood and causes mild motor impairment. Individuals may retain mobility throughout their lives but experience gradual weakening.

Symptoms of Spinal Muscular Atrophy

SMA symptoms vary based on the type but generally include:

• Muscle weakness and atrophy: Especially in the upper arms and legs

• Difficulty swallowing and breathing: Particularly in more severe cases

• Loss of motor skills: Such as sitting up, standing, or walking

• Scoliosis: A curvature of the spine, often seen in SMA patients

• Delayed motor development: Infants may show delayed milestones, such as holding their head up or sitting independently

Diagnosis of SMA

Diagnosing SMA usually involves a combination of physical exams, genetic testing, and sometimes electromyography (EMG) to assess muscle and nerve function. Genetic testing can confirm the absence or mutation of the SMN1 gene, which is the hallmark indicator of SMA.

Treatment Options for SMA

While SMA currently has no cure, several treatment options can significantly improve the quality of life for individuals affected by the condition. Early intervention is crucial for achieving optimal results. Treatment strategies for SMA include:

1. Gene Therapy

Gene therapy has emerged as a revolutionary approach for treating SMA, specifically with drugs like Zolgensma. This therapy delivers a functional copy of the SMN1 gene to the patient’s motor neurons, enabling the production of SMN protein. This treatment has shown promising results, particularly in young infants.

2. Spinraza (Nusinersen)

Spinraza is an FDA-approved drug that modifies SMN2, a backup gene to SMN1, to produce a more functional SMN protein. It is administered via spinal injections at regular intervals and has been shown to improve motor function in patients with SMA.

3. Evrysdi (Risdiplam)

Evrysdi is an oral medication that enhances SMN protein levels, which is particularly helpful for individuals who may find regular spinal injections challenging. Risdiplam is beneficial for both children and adults with SMA, helping maintain and improve motor function.

4. Supportive Therapies

In addition to medical treatments, various supportive therapies are vital in managing SMA. These include physical therapy, occupational therapy, respiratory support, and nutritional care to support muscle function and overall health.

Top Hospitals Specializing in SMA Treatment

For families seeking specialized care for SMA, several world-renowned hospitals offer advanced treatment options and multidisciplinary support for patients:

1. Essen University Hospital, Germany

   • Years in Operation: Over 115 years

   • Annual Patient Volume: Approximately 1.6 million

   • Global Ranking: Recognized among Germany's top hospitals for neurology and genetic research

Essen University Hospital has a long-standing reputation in Europe for its advanced research and treatment of neuromuscular and genetic disorders, including SMA. Their facility is equipped with state-of-the-art technology, and they offer access to groundbreaking treatments, making it a preferred choice for SMA patients worldwide.

2. Boston Children’s Hospital, USA

   • Years in Operation: Over 150 years

   • Annual Patient Volume: Over 1 million (including outpatient visits and specialty care)

   • Global Ranking: Consistently ranked #1 in the U.S. for pediatric neurology and neurosurgery

Boston Children’s Hospital is renowned globally, not only for its leading-edge treatments but also for its comprehensive research programs. The hospital provides a specialized SMA program that combines multidisciplinary expertise and innovative therapies, including gene therapy trials, to support children with this condition.

3. Great Ormond Street Hospital (GOSH), United Kingdom

   • Years in Operation: Over 170 years

   • Annual Patient Volume: Approximately 250,000 outpatient and inpatient visits annually

   • Global Ranking: Among the top 5 children's hospitals worldwide

As one of the oldest pediatric hospitals, GOSH has an exceptional legacy of treating complex and rare disorders like SMA. Known for its skilled neurology team and access to clinical trials, GOSH has a dedicated SMA care pathway that includes personalized treatment plans, supportive therapies, and family-centered care.

4. Quirónsalud Madrid, Spain

   • Years in Operation: Over 60 years

   • Annual Patient Volume: Over 2 million (across their network in Spain)

   • Global Ranking: Ranked as one of the top private hospitals in Europe for neurology and advanced treatments

Quirónsalud Madrid is a premier destination for neurology and neuromuscular treatment, known for its cutting-edge facilities and expertise in genetic therapies. Their team includes experienced neurologists who provide advanced SMA treatments, including gene therapy, to improve patient outcomes.

5. Medcare Women & Children Hospital, Dubai, UAE

   • Years in Operation: Over 7 years

   • Annual Patient Volume: Approximately 200,000

   • Global Ranking: Emerging as a leading center in the Middle East for pediatric neurology and gene therapy

Medcare Women & Children Hospital has rapidly become a global hub for treating SMA, offering life-changing gene therapy and holistic care to children from various countries. Under the leadership of Dr. Vivek Mundada, the hospital has successfully administered gene therapy to over 120 children with SMA from around the world. Their multidisciplinary approach and state-of-the-art facilities have positioned them as a beacon of hope for families seeking advanced SMA treatment.

Dr. Vivek Mundada - A Leading Specialist in Pediatric Neurology

When it comes to managing SMA and other complex pediatric neurological disorders, Dr. Vivek Mundada stands out for his expertise and compassionate approach. Dr. Mundada, a British Board-certified consultant pediatric neurologist, has an impressive track record of treating children with neurodevelopmental and neuromuscular conditions across the UK and the UAE.

“With his initiative, two children with SMA received gene therapy for the first time in the UAE in November 2020. Since then, Dr. Mundada has treated infants from multiple countries, helping them gain access to gene therapy and improve their quality of life.”

Dr. Mundada’s qualifications include an MBBS and DCH in India, followed by extensive training in the UK, where he received his CCT in Pediatric Neurodisability and Neurology. The Royal College of Paediatrics and Child Health awarded him both MRCPCH and FRCPCH credentials. His work in pediatric neurodisability and acquired brain injury is widely recognized, even acknowledged by the House of Lords, UK.

Dr. Mundada’s experience extends to some of the top hospitals in the UK, including the Royal London Hospital, Great Ormond Street Hospital, Addenbrookes Hospital, and Norfolk and Norwich University Hospital. His patient-centered approach, combined with his experience, has positioned him as a sought-after expert for families navigating the complexities of SMA.

Why Choose Medcare for SMA Treatment?

Under Dr. Mundada’s leadership, Medcare has become a trusted center for pediatric neurology, especially for families seeking comprehensive care for neuromuscular disorders like SMA. Medcare provides personalized treatment plans and access to the latest advancements in gene therapy, tailored to each child’s unique needs. With a collaborative team of specialists and state-of-the-art facilities, Medcare ensures families receive the support and care essential for managing SMA.

Medcare Women & Children Hospital has recently introduced a groundbreaking gene therapy treatment for Duchenne Muscular Dystrophy (DMD), providing new hope for patients from around the world. Among them is Cinar Atar, a six-year-old boy from Turkey who was diagnosed with DMD. This genetic condition leads to progressive muscle degeneration and severe physical limitations if untreated. Dr. Vivek and his team embarked on an intensive treatment plan for him. Dr. Vivek said:

"The treatment includes a one-time gene therapy infusion designed to deliver a shortened version of the dystrophin gene, known as micro-dystrophin, which helps produce a functional protein to strengthen muscles."

Chinar’s parents shared their emotional experiences:

“We were devastated by Cinar’s diagnosis and sought every possible way to help him. Volunteers and charities recommended Medcare Women & Children Hospital in Dubai, which is the only private hospital outside the US offering the treatment our child needed. We are immensely grateful for our child's health and the expertise of Dr. Vivek and the medical team. Their commitment and expertise have given our son a new lease on life.”

Navigating the journey of Spinal Muscular Atrophy can be overwhelming for families, but the advancements in gene therapy and specialized care have brought new hope. From groundbreaking gene therapy treatments to dedicated specialists like Dr. Vivek Mundada, the landscape of SMA treatment is more promising than ever. Hospitals like Essen University Hospital, Boston Children’s Hospital, Great Ormond Street Hospital, and Quirónsalud Madrid are at the forefront of SMA treatment, providing world-class care to patients worldwide.

How Can A-Medical Assist You in Achieving the Best Care for Spinal Muscular Atrophy (SMA) Treatment?

If you are seeking advanced, affordable treatment for Spinal Muscular Atrophy (SMA) in the best facilities worldwide, A-Medical health tourism company is here to support you. We provide all-inclusive packages that include hotel accommodations and airport transfers, ensuring a smooth and stress-free journey from the moment you arrive.

Let us help you take the first step toward effective SMA treatment. Contact us today to explore our services and create a personalized plan that meets your needs and priorities.

Reach out to us today:

• WhatsApp: +99410 310 93 33

• Email: [email protected]